Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$2.6 billion |
Valeant Pharmaceuticals International |
Medicis Pharmaceutical |
Sullivan & Cromwell - Ronald Creamer / Skadden, Arps, Meagher & Flom |
Weil, Gotshal & Manges / Latham & Watkins - Nicholas DeNovio |
Acquisition |
$944.4 million |
Weichai Power |
KION |
Hengeler Mueller / King & Wood Mallesons |
Freshfields Bruckhaus Deringer / Gleiss Lutz |
Acquisition |
$767.8 million |
Infra-PSP Canada |
Grupo Isolux Corsán |
Lefosse Advogados / Linklaters |
|
Acquisition |
$300 million |
OTPP |
Manabi Minerais |
Lefosse Advogados |
|
Acquisition |
$158.5 million |
Warburg Pincus |
Endurance Energy |
Stikeman Elliott / Willkie Farr & Gallagher |
|
Acquisition |
$129.8 million |
Twin Butte Energy |
Waseca Energy |
Stikeman Elliott - Julie D’Avignon |
|
Acquisition |
$116.8 million |
FormFactor |
Astria Semiconductor Holdings (MicroProbe) |
Davis Polk & Wardwell - Rachel Kleinberg |
DLA Piper |
Acquisition |
$95 million |
Meda |
Jazz Pharmaceuticals |
Covington & Burling - Rob Heller |
|
Acquisition |
Undisclosed |
Franchise Services of North America |
Simply Wheelz |
Stikeman Elliott / Edinger Associates / Paul Hastings |
Sidley Austin / Blake, Cassels & Graydon |
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/arrangers |
Adviser to issuer/borrower (tax) |
Adviser to lead managers (tax) |
Initial Public Offering |
$4.2 billion |
Banco Santander (Grupo Financiero Santander) |
Barclays / Citigroup / Credit Suisse / Goldman Sachs / JPMorgan / RBC Capital |
Davis Polk & Wardwell |
Shearman & Sterling |
Deals of the week - September 10 2012
